Genetron Holdings (Genetron Holdings) Ending Cash Position : $0.00 Mil (As of Jun. 2022)

View and export this data going back to 2020. Start your Free Trial

What is Genetron Holdings Ending Cash Position?

Genetron Holdings's Ending Cash Position for the quarter that ended in Jun. 2022 was $0.00 Mil.

Genetron Holdings's annual Ending Cash Position declined from Dec. 2020 ($210.38 Mil) to Dec. 2021 ($100.33 Mil) and declined from Dec. 2021 ($100.33 Mil) to Dec. 2022 ($25.28 Mil).

Genetron Holdings Ending Cash Position Historical Data

The historical data trend for Genetron Holdings's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genetron Holdings Ending Cash Position Chart

Genetron Holdings Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Ending Cash Position

Get a 7-Day Free Trial

9.03

19.95

210.38

100.33

25.28

Genetron Holdings Quarterly Data
	Dec17	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Dec22
Ending Cash Position	Get a 7-Day Free Trial													-	-	-	-	-

Genetron Holdings Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Genetron Holdings's Ending Cash Position for the fiscal year that ended in Dec. 2022 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	91.661	+	-66.378
	=	25.28

Genetron Holdings's Ending Cash Position for the quarter that ended in Jun. 2022 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	0	+	0
	=	0.00

Genetron Holdings Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Genetron Holdings's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Genetron Holdings (Genetron Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genetron Holdings Ltd (NAS:GTH) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 8 Life Science Parkway, 1-2nd Floor, Building 11, Zone 1, Changping District, Beijing, CHN, 102206

Website

https://www.genetronhealth.com

Genetron Holdings Ltd is an oncology company in China. It is specialized in cancer molecular profiling and harnesses advanced technologies in molecular biology and data science to transform cancer treatment. The company's operating segment includes Diagnosis and monitoring - provision for LDT services; Diagnosis and monitoring - sale of IVD products and Development services. It generates maximum revenue from the Diagnosis and monitoring - provision for LDT services segment.